Protector effect of α-thalassaemia on cholecystitis and cholecystectomy in sickle cell disease

References

• Chaar V, Kéclard L, Diara JP, et al. Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia. Haematologica. 2005;90(2):188–199.
   PubMed Web of Science ®Google Scholar
• Haverfield EV, McKenzie CA, Forrester T, et al. UGT1A1 variation and gallstone formation in sickle cell disease. Blood. 2004;105(3):968–972. doi: 10.1182/blood-2004-02-0521
   PubMed Web of Science ®Google Scholar
• Walker TM, Hambleton IR, Serjeant GR. Gallstones in sickle cell disease: observations from the Jamaican Cohort study. J Pediatr. 2000;136(1):80–85. doi: 10.1016/S0022-3476(00)90054-4
   PubMed Web of Science ®Google Scholar
• Currò G, Meo A, Ippolito D, et al. Asymptomatic cholelithiasis in children with sickle cell disease: early or delayed cholecystectomy? Ann Surg. 2007;245(1):126–129. doi: 10.1097/01.sla.0000242716.66878.23
   PubMed Web of Science ®Google Scholar
• Steinberg MH, Embury SH. Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene. Blood. 1986;68(5):985–990.
   PubMed Web of Science ®Google Scholar
• Ballas SK. Effect of alpha-globin genotype on the pathophysiology of sickle cell disease. Pediatr Pathol Mol Med. 2001;20(2):107–121.
   PubMedGoogle Scholar
• Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21(1):37–47. doi: 10.1016/j.blre.2006.07.001
   PubMed Web of Science ®Google Scholar
• Haider MZ, Ashebu S, Aduh P, et al. Influence of alpha-thalassemia on cholelithiasis in SS patients with elevated Hb F. Acta Haematol. 1998;100(3):147–150. doi: 10.1159/000040890
   PubMed Web of Science ®Google Scholar
• Adekile A, Kutlar F, McKie K, et al. The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia. Eur J Haematol. 2005;75(2):150–155. doi: 10.1111/j.1600-0609.2005.00477.x
   PubMed Web of Science ®Google Scholar
• Chaar V, Kéclard L, Etienne-Julan M, et al. UGT1A1 polymorphism outweighs the modest effect of deletional (-3.7 kb) alpha-thalassemia on cholelithogenesis in sickle cell anemia. Am J Hematol. 2006;81(5):377–379. doi: 10.1002/ajh.20574
   PubMed Web of Science ®Google Scholar
• Vasavda N, Menzel S, Kondaveeti S, et al. The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease. Br J Haematol. 2007;138(2):263–270. doi: 10.1111/j.1365-2141.2007.06643.x
   PubMed Web of Science ®Google Scholar
• Martins R, Morais A, Dias A, et al. Early modification of sickle cell disease clinical course by UDP-glucuronosyltransferase 1A1 gene promoter polymorphism. J Hum Genet. 2008;53(6):524–528. doi: 10.1007/s10038-008-0281-3
   PubMed Web of Science ®Google Scholar
• Alkindi SY, Pathare A, Al Zadjali S, et al. Serum total bilirubin, not cholelithiasis, is influenced by UGT1A1 polymorphism, alpha thalassemia and β(s) haplotype: first report on comparison between Arab-Indian and African β(s) Genes. Mediterr J Hematol Infect Dis. 2015 Nov 1;7(1):e2015060. doi: 10.4084/mjhid.2015.060
   PubMed Web of Science ®Google Scholar
• Kimura Y, Takada T, Kawarada Y, et al. Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007;14(1):15–26. doi: 10.1007/s00534-006-1152-y
   PubMedGoogle Scholar
• Van Vranken M. Evaluation of microcytosis. Am Fam Physician. 2010;82(9):1117–1122.
   PubMed Web of Science ®Google Scholar
• Chong SS, Boehm CD, Higgs DR, et al. Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood. 2000;95(1):360–362.
   PubMed Web of Science ®Google Scholar
• Steinberg MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol. 2005;129(4):465–481. doi: 10.1111/j.1365-2141.2005.05411.x
   PubMed Web of Science ®Google Scholar
• Joly P, Pondarré C, Bardel C, et al. The alpha-globin genotype does not influence sickle cell disease severity in a retrospective cross-validation study of the pediatric severity score. Eur J Haematol. 2012;88(1):61–67. doi: 10.1111/j.1600-0609.2011.01705.x
   PubMed Web of Science ®Google Scholar
• Sonati MF, Farah SB, Ramalho AS, et al. High prevalence of alpha-thalassemia in a black population of Brazil. Hemoglobin. 1991;15(4):309–311. doi: 10.3109/03630269109027884
   PubMed Web of Science ®Google Scholar
• Wenning MR, Kimura EM, Costa FF, et al. Alpha-globin genes: thalassemic and structural alterations in a Brazilian population. Braz J Med Biol Res. 2000;33(9):1041–1045. doi: 10.1590/S0100-879X2000000900008
   PubMed Web of Science ®Google Scholar
• Wagner SC, de Castro SM, Gonzalez TP, et al. Neonatal screening for hemoglobinopathies: results of a public health system in South Brazil. Genet Test Mol Biomarkers. 2010;14(4):565–569. doi: 10.1089/gtmb.2010.0008
   PubMed Web of Science ®Google Scholar
• Fleury MK. Haplotypes of beta-globin gene in sickle cell anemia patients of Rio de Janeiro, Brazil. Rev Bras Hematol Hemoter. 2001;23(1):57–58. doi: 10.1590/S1516-84842001000100011
   Google Scholar
• Filho IL, Ribeiro GS, Moura PG, et al. Sickle cell disease: acute clinical manifestations in early childhood and molecular characteristics in a group of children in Rio de Janeiro. Rev Braz Hematol Hemoter. 2012;34(3):196–201. doi: 10.5581/1516-8484.20120049
   PubMedGoogle Scholar
• Rumaney MB, Ngo Bitoungui VJ, Vorster AA, et al. The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival. PLoS One. 2014;9(6):e100516. doi: 10.1371/journal.pone.0100516
   PubMed Web of Science ®Google Scholar
• Wiles N, Howard J. Role of hydroxicarbamide in prevention of complications in patients with sickle cell disease. Ther Clin Risk Manag. 2009;5:745–755.
   PubMedGoogle Scholar
• Steinberg MH, McCarthy WF, Castro O, et al. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up. Am J Hematol. 2010;85(6):403–408.
   PubMed Web of Science ®Google Scholar
• Mallouh A, Burke GM, Salamah M, et al. Splenic function in Saudi children with sickle cell disease. Ann Trop Paediatr. 1984;4(2):87–91. doi: 10.1080/02724936.1984.11748315
   PubMedGoogle Scholar
• Adekile AD, Tuli M, Haider MZ, et al. Influence of alpha-thalassemia trait on spleen function in sickle cell anemia patients with high HbF. Am J Hematol. 1996;53(1):1–5. doi: 10.1002/(SICI)1096-8652(199609)53:1<1::AID-AJH1>3.0.CO;2-V
   PubMed Web of Science ®Google Scholar
• Wali YA, Al-Lamki Z, Hussein SS, et al. Splenic function in Omani children with sickle cell disease: correlation with severity index, hemoglobin phenotype, iron status, and alpha-thalassemia trait. Pediatr Hematol Oncol. 2002;19(7):491–500. doi: 10.1080/08880010290097314
   PubMed Web of Science ®Google Scholar